Evaluation of the introduction of a telemedical network to improve stroke management and secondary prevention (Trans Regional Network for stroke intervention with telemedicine)

Evaluation of the introduction of a telemedical network to improve stroke management and secondary prevention (Trans Regional Network for stroke intervention with telemedicine) - TRANSIT-Stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011696

Enrollment

7500

Registered

2017-08-11

Start date

2014-10-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I64 I61 G45 I63

Interventions

Group 1: Arm 1: Patients taken to a hospital without stroke unit (level-I-clinic) or with a regional stroke unit (level-II-clinic) get a supportive examination via telemedicine by an experienced consu

it is checked whether they are reached or exceeded by clinics involved in TRANSIT. The quality of secondary prevention is described by comparing medication documented at discharge and medication after

thus, on patient level the assignment is cluster randomized. There is no intervention. The teleconsultations are not dependent on the study

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written consent of the patient or legal representative for the follow-up question All stroke or TIA patients in randomly selected I and II clinics of the TRANSIT-Stroke network selected by the attending physician.

Exclusion criteria

Exclusion criteria: Age <18 years No stroke or TIA

Design outcomes

Primary

Measure	Time frame
Fulfillment of targets with regard to standardized quality indicators of acute-care treatment in participating hospitals after 3 years; Proportion of stroke or TIA patients with guideline-appropriate secondary prophylaxis 3 months after occurrence (secondary prevention consortium) The quality indicators were defined in a standardized approach according to national and international recommendations. The process of developing evidence-based quality indicators was developed in November 2003 at the initiative of the German Stroke Register (ADSR) in cooperation with representatives of the German Stroke Society (DSG), the German Society of Neurology (DGN), the German Stroke Foundation As well as quality assurance specialists for stroke management, and was successfully completed in 2006. The quality indicators include results and process indicators. Since 01.01.2013, all hospitals in Bavaria have been obliged to participate in the quality assurance project "Stroke" of the Bavarian Association for Quality Assurance in Inpatient Care (BAQ).	—

Measure

Time frame

Fulfillment of targets with regard to standardized quality indicators of acute-care treatment in participating hospitals after 3 years; Proportion of stroke or TIA patients with guideline-appropriate secondary prophylaxis 3 months after occurrence (secondary prevention consortium) The quality indicators were defined in a standardized approach according to national and international recommendations. The process of developing evidence-based quality indicators was developed in November 2003 at the initiative of the German Stroke Register (ADSR) in cooperation with representatives of the German Stroke Society (DSG), the German Society of Neurology (DGN), the German Stroke Foundation As well as quality assurance specialists for stroke management, and was successfully completed in 2006. The quality indicators include results and process indicators. Since 01.01.2013, all hospitals in Bavaria have been obliged to participate in the quality assurance project "Stroke" of the Bavarian Association for Quality Assurance in Inpatient Care (BAQ).

—

Secondary

Measure	Time frame
The outcome of the patients is collected after 3 months by means of a written or telephone survey. Clinical outcome of thrombectomized patients at discharge and at 3 months. A) Clinical outcome of the patients after 3 months (defined by proportion of patients with Barthel index <60, new institutionalization or death) B) Influence of patient-related (e.g., comorbidities) as well as structural factors (e.g., stage of the treating clinic) on the outcome after 3 months. C) Influence of the secondary prevention consensus on the proportion of patients with guideline-appropriate secondary prophylaxis after 3 and 12 months The following scores are used here: Barthel-Index modified Rankin Scale (mRS) Satisfaction with Stroke Care Questionnaire (SASC) EQ-5D-5L PHQ-9 Relatives survey on the care burden Patient knowledge of risk factors	—

Measure

Time frame

The outcome of the patients is collected after 3 months by means of a written or telephone survey. Clinical outcome of thrombectomized patients at discharge and at 3 months. A) Clinical outcome of the patients after 3 months (defined by proportion of patients with Barthel index <60, new institutionalization or death) B) Influence of patient-related (e.g., comorbidities) as well as structural factors (e.g., stage of the treating clinic) on the outcome after 3 months. C) Influence of the secondary prevention consensus on the proportion of patients with guideline-appropriate secondary prophylaxis after 3 and 12 months The following scores are used here: Barthel-Index modified Rankin Scale (mRS) Satisfaction with Stroke Care Questionnaire (SASC) EQ-5D-5L PHQ-9 Relatives survey on the care burden Patient knowledge of risk factors

—

Countries

Germany

Contacts

Public ContactKatharina Gabriel

Institut für Klinische Epidemiologie und Biometrie

Katharina.Gabriel@uni-wuerzburg.de093120147305

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026